Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 192 | 170 | 195 | 131 | 253 |
| Gross Profit | 192 | 170 | 195 | 131 | 253 |
| Operating Expenses | 742 | 586 | 643 | 636 | 544 |
| Operating Income | -550 | -416 | -448 | -506 | -291 |
| Interest Expense | -13,414,980 | 13,415,000 | -6 | 1,137 | 1,345 |
| Other Income | -13,414,978 | 13,415,014 | 0 | 0 | 1,038 |
| Pre-tax Income | -548 | -403 | -442 | -1,643 | -598 |
| Income Tax | 99 | -50 | N/A | N/A | 165 |
| Net Income Continuous | -647 | -353 | -442 | -1,643 | -763 |
| Net Income | $-647 | $-353 | $-442 | $-1,643 | $-763 |
| EPS Basic Total Ops | -0.03 | -0.03 | -0.02 | -0.10 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.02 | -0.10 | -0.05 |
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.02 | -0.10 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.02 | -0.10 | -0.05 |
| EBITDA(a) | $-544 | $-408 | $-437 | $519 | $-44 |